Brian Perkins Really? Well it's great that companies invest in R&D and can get a return... BUT presently that RETURN is on the backs of US consumers - Ex-US the drugs cost a fraction of what US taxpayers pay... The US govt should insist on fair pricing by stipulating that US price cannot be say 20% max more than the average price in other developed nations. In the US we have Direct to Consumer advertising - in Europe they don't. A lot of US Pharm spnd as much and MORE on marketing and sales than on R&D. They are getting a return on the Marketing and their legal costs more than R&D these days!! Read the article - Abbvie had a patent for a fair number of years - the extensions are a joke.

Brian Perkins Really? Well it's great that companies invest in R&D and can get a return... BUT presently that RETURN is on the backs of US consumers - Ex-US the drugs cost a fraction of what US taxpayers pay... The US govt should insist on fair pricing by stipulating that US price cannot be say 20% max more than the average price in other developed nations. In the US we have Direct to Consumer advertising - in Europe they don't. A lot of US Pharm spnd as much and MORE on marketing and sales than on R&D. They are getting a return on the Marketing and their legal costs more than R&D these days!! Read the article - Abbvie had a patent for a fair number of years - the extensions are a joke.

user
yes
assistant